TY - JOUR AU - Younossi, Z. M. AU - Kanwal, F. AU - Saab, S. AU - Brown, K. A. AU - El-Serag, H. B. AU - Kim, W. R. AU - Ahmed, A. AU - Kugelmas, M. AU - Gordon, S. C. PY - 2014 DA - 2014// TI - The impact of hepatitis C burden: an evidence-based approach JO - Aliment Pharmacol Ther VL - 39 UR - https://doi.org/10.1111/apt.12625 DO - 10.1111/apt.12625 ID - Younossi2014 ER - TY - JOUR AU - Galbraith, J. W. AU - Franco, R. A. AU - Donnelly, J. P. AU - Rodgers, J. B. AU - Morgan, J. M. AU - Viles, A. F. AU - Overton, E. T. AU - Saag, M. S. AU - Wang, H. E. PY - 2015 DA - 2015// TI - Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department JO - Hepatology VL - 61 UR - https://doi.org/10.1002/hep.27410 DO - 10.1002/hep.27410 ID - Galbraith2015 ER - TY - JOUR AU - Sears, D. M. AU - Cohen, D. C. AU - Ackerman, K. AU - Ma, J. E. AU - Song, J. PY - 2013 DA - 2013// TI - Birth cohort screening for chronic hepatitis during colonoscopy appointments JO - Am J Gastroenterol VL - 108 UR - https://doi.org/10.1038/ajg.2013.50 DO - 10.1038/ajg.2013.50 ID - Sears2013 ER - TY - STD TI - Turner BJ, Taylor BS, Hanson, Perez ME, Hernandez L, Villarreal R, Veerapaneni P, Fiebelkorn K. Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs. J Hosp Med. 2015 May 29. doi: 10.1002/jhm.2376. [Epub ahead of print]. ID - ref4 ER - TY - JOUR AU - Morano, J. P. AU - Zelenev, A. AU - Lombard, A. AU - Marcus, R. AU - Gibson, B. A. AU - Altice, F. L. PY - 2014 DA - 2014// TI - Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic JO - Community Health VL - 39 UR - https://doi.org/10.1007/s10900-014-9932-9 DO - 10.1007/s10900-014-9932-9 ID - Morano2014 ER - TY - JOUR AU - Rosenthal, E. AU - Cacoub, P. PY - 2015 DA - 2015// TI - Extrahepatic manifestations in chronic hepatitis C virus carriers JO - Lupus VL - 24 UR - https://doi.org/10.1177/0961203314556140 DO - 10.1177/0961203314556140 ID - Rosenthal2015 ER - TY - JOUR AU - Younossi, Z. M. AU - Singer, M. E. AU - Mir, H. M. AU - Henry, L. AU - Hunt, S. PY - 2014 DA - 2014// TI - Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2013.11.009 DO - 10.1016/j.jhep.2013.11.009 ID - Younossi2014 ER - TY - JOUR AU - Coretti, S. AU - Romano, F. AU - Orlando, V. AU - Codella, P. AU - Prete, S. AU - Brino, E. AU - Ruggeri, M. PY - 2015 DA - 2015// TI - Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature JO - Risk Manag Healthc Policy VL - 8 ID - Coretti2015 ER - TY - STD TI - Estes C, Abdel-Kareem M, Abdel-Razek W, Abdel-Sameea E, Abuzeid M, Gomaa A, Osman W, Razavi H, Zaghla H, Waked I. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.Aliment Pharmacol Ther. 2015 Jul 22. doi: 10.1111/apt.13316. [Epub ahead of print]. ID - ref9 ER - TY - JOUR AU - John-Baptiste, A. A. AU - Tomlinson, G. AU - Hsu, P. C. AU - Krajden, M. AU - Heathcote, E. J. AU - Laporte, A. AU - Yoshida, E. M. AU - Anderson, F. H. AU - Krahn, M. D. PY - 2009 DA - 2009// TI - Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C JO - Am J Gastroenterol VL - 104 UR - https://doi.org/10.1038/ajg.2009.346 DO - 10.1038/ajg.2009.346 ID - John-Baptiste2009 ER - TY - JOUR AU - North, C. S. AU - Hong, B. A. AU - Adewuyi, S. A. AU - Pollio, D. E. AU - Jain, M. K. AU - Devereaux, R. AU - Quartey, N. A. AU - Ashitey, S. AU - Lee, W. M. AU - Lisker-Melman, M. PY - 2013 DA - 2013// TI - Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations JO - Gen Hosp Psychiatry VL - 35 UR - https://doi.org/10.1016/j.genhosppsych.2012.11.002 DO - 10.1016/j.genhosppsych.2012.11.002 ID - North2013 ER - TY - JOUR AU - Younossi, Z. M. AU - Stepanova, M. AU - Sulkowski, M. AU - Naggie, S. AU - Hunt, S. H. PY - 2015 DA - 2015// TI - All Oral Therapy With Sofosbuvir Plus Ribavirin For the Treatment of Chronic Hepatitis C in Patients Co-infected With HIV (PHOTON-1 and PHOTON 2): The Impact on Patient-Reported Outcomes JO - J Infect Dis VL - 212 UR - https://doi.org/10.1093/infdis/jiv005 DO - 10.1093/infdis/jiv005 ID - Younossi2015 ER - TY - JOUR AU - Bonkovsky, H. L. AU - Snow, K. K. AU - Malet, P. F. AU - Back-Madruga, C. AU - Fontana, R. J. AU - Sterling, R. K. AU - Kulig, C. C. AU - Bisceglie, A. M. AU - Morgan, T. R. AU - Dienstag, J. L. AU - Ghany, M. G. AU - Gretch, D. R. PY - 2007 DA - 2007// TI - Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis JO - J Hepatol VL - 46 UR - https://doi.org/10.1016/j.jhep.2006.10.009 DO - 10.1016/j.jhep.2006.10.009 ID - Bonkovsky2007 ER - TY - JOUR AU - Fazel, Y. AU - Lam, B. AU - Golabi, P. AU - Younossi, Z. PY - 2015 DA - 2015// TI - Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C JO - Expert Opin Drug Saf VL - 14 UR - https://doi.org/10.1517/14740338.2015.1053868 DO - 10.1517/14740338.2015.1053868 ID - Fazel2015 ER - TY - JOUR AU - Lawitz, E. AU - Mangia, A. AU - Wyles, D. AU - Rodriguez-Torres, M. AU - Hassanein, T. AU - Gordon, S. C. AU - Schultz, M. AU - Davis, M. N. AU - Kayali, Z. AU - Reddy, K. R. AU - Jacobson, I. M. AU - Kowdley, K. V. AU - Nyberg, L. AU - Subramanian, G. M. AU - Hyland, R. H. AU - Arterburn, S. AU - Jiang, D. AU - McNally, J. AU - Brainard, D. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Sheikh, A. M. AU - Younossi, Z. AU - Gane, E. J. PY - 2013 DA - 2013// TI - Sofosbuvir for previously untreated chronic hepatitis C infection JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214853 DO - 10.1056/NEJMoa1214853 ID - Lawitz2013 ER - TY - JOUR AU - Poordad, F. AU - Lawitz, E. AU - Kowdley, K. V. AU - Cohen, D. E. AU - Podsadecki, T. AU - Siggelkow, S. AU - Heckaman, M. AU - Larsen, L. AU - Menon, R. AU - Koev, G. AU - Tripathi, R. AU - Pilot-Matias, T. AU - Bernstein, B. PY - 2013 DA - 2013// TI - Exploratory study of oral combination antiviral therapy for hepatitis C JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1208809 DO - 10.1056/NEJMoa1208809 ID - Poordad2013 ER - TY - JOUR AU - Jacobson, I. M. AU - Gordon, S. C. AU - Kowdley, K. V. AU - Yoshida, E. M. AU - Rodriguez-Torres, M. AU - Sulkowski, M. S. AU - Shiffman, M. L. AU - Lawitz, E. AU - Everson, G. AU - Bennett, M. AU - Schiff, E. AU - Al-Assi, M. T. AU - Subramanian, G. M. AU - An, D. AU - Lin, M. AU - McNally, J. AU - Brainard, D. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Patel, K. AU - Feld, J. AU - Pianko, S. AU - Nelson, D. R. PY - 2013 DA - 2013// TI - Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214854 DO - 10.1056/NEJMoa1214854 ID - Jacobson2013 ER - TY - JOUR AU - Afdhal, N. AU - Zeuzem, S. AU - Kwo, P. AU - Chojkier, M. AU - Gitlin, N. AU - Puoti, M. AU - Romero-Gomez, M. AU - Zarski, J. P. AU - Agarwal, K. AU - Buggisch, P. AU - Foster, G. R. AU - Bräu, N. AU - Buti, M. AU - Jacobson, I. M. AU - Subramanian, G. M. AU - Ding, X. AU - Mo, H. AU - Yang, J. C. AU - Pang, P. S. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Muir, A. J. AU - Mangia, A. AU - Marcellin, P. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402454 DO - 10.1056/NEJMoa1402454 ID - Afdhal2014 ER - TY - JOUR AU - Afdhal, N. AU - Reddy, K. R. AU - Nelson, D. R. AU - Lawitz, E. AU - Gordon, S. C. AU - Schiff, E. AU - Nahass, R. AU - Ghalib, R. AU - Gitlin, N. AU - Herring, R. AU - Lalezari, J. AU - Younes, Z. H. AU - Pockros, P. J. AU - Bisceglie, A. M. AU - Arora, S. AU - Subramanian, G. M. AU - Zhu, Y. AU - Dvory-Sobol, H. AU - Yang, J. C. AU - Pang, P. S. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Muir, A. J. AU - Sulkowski, M. AU - Kwo, P. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1316366 DO - 10.1056/NEJMoa1316366 ID - Afdhal2014 ER - TY - JOUR AU - Zeuzem, S. AU - Dusheiko, G. M. AU - Salupere, R. AU - Mangia, A. AU - Flisiak, R. AU - Hyland, R. H. AU - Illeperuma, A. AU - Svarovskaia, E. AU - Brainard, D. M. AU - Symonds, W. T. AU - Subramanian, G. M. AU - McHutchison, J. G. AU - Weiland, O. AU - Reesink, H. W. AU - Ferenci, P. AU - Hézode, C. AU - Esteban, R. PY - 2014 DA - 2014// TI - Sofosbuvir and ribavirin in HCV genotypes 2 and 3 JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1316145 DO - 10.1056/NEJMoa1316145 ID - Zeuzem2014 ER - TY - JOUR AU - Kowdley, K. V. AU - Gordon, S. C. AU - Reddy, K. R. AU - Rossaro, L. AU - Bernstein, D. E. AU - Lawitz, E. AU - Shiffman, M. L. AU - Schiff, E. AU - Ghalib, R. AU - Ryan, M. AU - Rustgi, V. AU - Chojkier, M. AU - Herring, R. AU - Bisceglie, A. M. AU - Pockros, P. J. AU - Subramanian, G. M. AU - An, D. AU - Svarovskaia, E. AU - Hyland, R. H. AU - Pang, P. S. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Muir, A. J. AU - Pound, D. AU - Fried, M. W. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402355 DO - 10.1056/NEJMoa1402355 ID - Kowdley2014 ER - TY - JOUR AU - Dalgard, O. AU - Bjøro, K. AU - Ring-Larsen, H. AU - Bjornsson, E. AU - Holberg-Petersen, M. AU - Skovlund, E. AU - Reichard, O. AU - Myrvang, B. AU - Sundelöf, B. AU - Ritland, S. AU - Hellum, K. AU - Frydén, A. AU - Florholmen, J. AU - Verbaan, H. PY - 2008 DA - 2008// TI - Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response JO - Hepatology VL - 47 UR - https://doi.org/10.1002/hep.21975 DO - 10.1002/hep.21975 ID - Dalgard2008 ER - TY - STD TI - Press release- http://www.prnewswire.com/news-releases/abbvie-completes-largest-phase-iii-program-of-an-all-oral-interferon-free-therapy-for-the-treatment-of-hepatitis-c-genotype-1-242911871.html Last accessed on 30 July 2015. UR - http://www.prnewswire.com/news-releases/abbvie-completes-largest-phase-iii-program-of-an-all-oral-interferon-free-therapy-for-the-treatment-of-hepatitis-c-genotype-1-242911871.html ID - ref23 ER - TY - JOUR AU - Nachega, J. B. AU - Parienti, J. AU - Olalekan, J. AU - Uthman, A. AU - Gross, R. AU - Dowdy, D. W. AU - Sax, D. E. AU - Gallant, J. E. AU - Mugavero, M. J. AU - Mills, E. J. AU - Giordano, T. P. PY - 2014 DA - 2014// TI - Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials JO - Clin Infect Dis VL - 58 UR - https://doi.org/10.1093/cid/ciu046 DO - 10.1093/cid/ciu046 ID - Nachega2014 ER - TY - STD TI - Kowdley KV, Lawitz E, Poordad F, et al. Safety and efficacy of interferon-free regimens of ABT-450/r, ABT-267. ABT-333 ± ribavirin in patients with chronic HCV GT1 infection: results from the Aviator study. Poster presented at the 48th Annual Meeting of the European Association for the Study of the Liver; April 24-28, 2013; Amsterdam, The Netherlands. ID - ref25 ER - TY - STD TI - Baran RW, Xie W, Liu Y, Cohen DE, Gooch K. Health related quality of Life (HRQoL), health state, function and wellbeing of chronic HCV patients treated with interferon-free, oral DAA regimens: patient reported outcome (PRO) results from the Aviator study. Poster presented at: 64th Annual Meeting of the American Association for the Study of Liver Disease: Nov 1-5 2013; Washington, DC. P 1113. ID - ref26 ER - TY - STD TI - Press release: OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C. Obtained from the world wide web at http://www.jnj.com/news/all/OLYSIO-simeprevir-Receives-FDA-Approval-for-Combination-Treatment-of-Chronic-Hepatitis-C. Last accessed on 30 July 2015. UR - http://www.jnj.com/news/all/OLYSIO-simeprevir-Receives-FDA-Approval-for-Combination-Treatment-of-Chronic-Hepatitis-C ID - ref27 ER - TY - JOUR AU - Scott, J. AU - Rosa, K. AU - Fu, M. AU - Cerri, K. AU - Peeters, M. AU - Beumont, M. AU - Zeuzem, S. AU - Evon, D. M. AU - Gilles, L. PY - 2014 DA - 2014// TI - Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection JO - BMC Infect Dis VL - 14 UR - https://doi.org/10.1186/1471-2334-14-465 DO - 10.1186/1471-2334-14-465 ID - Scott2014 ER - TY - JOUR AU - Jacobson, I. M. AU - Dore, G. J. AU - Foster, G. R. AU - Fried, M. W. AU - Radu, M. AU - Rafalsky, V. V. AU - Moroz, L. AU - Craxi, A. AU - Peeters, M. AU - Lenz, O. AU - Ouwerkerk-Mahadevan, S. AU - Rosa, G. AU - Kalmeijer, R. AU - Scott, J. AU - Sinha, R. AU - Beumont-Mauviel, M. PY - 2014 DA - 2014// TI - Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)60494-3 DO - 10.1016/S0140-6736(14)60494-3 ID - Jacobson2014 ER - TY - STD TI - Stepanova M, Younossi ZM. Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage. Dig Dis Sci. 2015 May 19. doi: 10.1007/s10620-015-3709-6. ID - ref30 ER - TY - JOUR AU - McGowan, C. E. AU - Fried, M. W. PY - 2012 DA - 2012// TI - Barriers to hepatitis C treatment JO - Liver Int VL - 32 UR - https://doi.org/10.1111/j.1478-3231.2011.02706.x DO - 10.1111/j.1478-3231.2011.02706.x ID - McGowan2012 ER - TY - JOUR AU - Gundlapalli, A. V. AU - Nelson, R. E. AU - Haroldsen, C. AU - Carter, M. E. AU - LaFleur, J. PY - 2015 DA - 2015// TI - Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009 JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0132056 DO - 10.1371/journal.pone.0132056 ID - Gundlapalli2015 ER - TY - STD TI - Appleby J. VA, California Panels Urge Costly Hepatitis C Drugs For Sickest Patients. April 17,2014. Obtained from the world wide web at http://www.kaiserhealthnews.org/Stories/2014/April/17/hepatitis-c-sovaldi-panels-urge-approval.aspx. Last accessed on Jul 30, 2015. UR - http://www.kaiserhealthnews.org/Stories/2014/April/17/hepatitis-c-sovaldi-panels-urge-approval.aspx ID - ref33 ER - TY - JOUR AU - Stepanova, M. AU - Kanwal, F. AU - El-Serag, H. AU - Younossi, Z. M. PY - 2011 DA - 2011// TI - Insurance Status and Treatment Candidacy of Hepatitis C Patients: Analysis of Population-based Data from the United States JO - Hepatology VL - 53 UR - https://doi.org/10.1002/hep.24131 DO - 10.1002/hep.24131 ID - Stepanova2011 ER - TY - STD TI - Cohn J, Roberts T, Amorosa V, Lemoine M, Hill A. Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment. Curr Opin HIV AIDS. 2015 Jul 17. [Epub ahead of print] ID - ref35 ER - TY - STD TI - U.S. Department Of Health And Human Services/Centers for Disease Control and Prevention (CDC). Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease. MMWR, Oct 16, 1998. Last accessed on 30 July 2015 at http://www.cdc.gov/mmwr/PDF/rr/rr4719.PDF. UR - http://www.cdc.gov/mmwr/PDF/rr/rr4719.PDF ID - ref36 ER - TY - JOUR AU - Younossi, Z. M. AU - Stepanova, M. AU - Afendy, M. AU - Lam, B. P. AU - Mishra, A. PY - 2013 DA - 2013// TI - Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C JO - J Viral Hepat VL - 20 UR - https://doi.org/10.1111/jvh.12080 DO - 10.1111/jvh.12080 ID - Younossi2013 ER - TY - STD TI - U.S. Department Of Health And Human Services/Centers for Disease Control and Prevention (CDC). HEPATITIS C: Why Baby Boomers Should Get Tested. Available at: http://www.cdc.gov/knowmorehepatitis/Media/PDFs/FactSheet-Boomers.pdf. Last accessed at 30 July 2015. UR - http://www.cdc.gov/knowmorehepatitis/Media/PDFs/FactSheet-Boomers.pdf ID - ref38 ER - TY - JOUR AU - Galbraith, J. W. AU - Donnelly, J. P. AU - Franco, R. A. AU - Overton, E. T. AU - Rodgers, J. B. AU - Wang, H. E. PY - 2014 DA - 2014// TI - National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States JO - Clin Infect Dis VL - 59 UR - https://doi.org/10.1093/cid/ciu427 DO - 10.1093/cid/ciu427 ID - Galbraith2014 ER - TY - JOUR AU - Razavi, H. AU - Elkhoury, A. C. AU - Elbasha, E. AU - Estes, C. AU - Pasini, K. AU - Poynard, T. AU - Kumar, R. PY - 2013 DA - 2013// TI - Chronic hepatitis C virus (HCV) disease burden and cost in the United States JO - Hepatology VL - 57 UR - https://doi.org/10.1002/hep.26218 DO - 10.1002/hep.26218 ID - Razavi2013 ER - TY - STD TI - Smith B, Morgan R, Beckett G, Falk-Yetter Y, Holtzman D, Teo C, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4);1–32. ID - ref41 ER - TY - JOUR AU - Moyer, V. A. PY - 2013 DA - 2013// TI - Screening for Hepatitis C Virus Infection in Adults: U.S JO - Preventive Services Task Force Recommendation Statement Ann Intern Med VL - 159 ID - Moyer2013 ER - TY - JOUR AU - Ware, J. E. AU - Kosinski, M. PY - 2001 DA - 2001// TI - Interpreting SF-36 summary health measures: a response JO - Qual Life Res VL - 10 UR - https://doi.org/10.1023/A:1012588218728 DO - 10.1023/A:1012588218728 ID - Ware2001 ER - TY - JOUR AU - Younossi, Z. M. AU - Guyatt, G. AU - Kiwi, M. AU - Boparai, N. AU - King, D. PY - 1999 DA - 1999// TI - Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease JO - Gut VL - 45 UR - https://doi.org/10.1136/gut.45.2.295 DO - 10.1136/gut.45.2.295 ID - Younossi1999 ER - TY - STD TI - Younossi ZM, Stepanova M, Henry L. Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C. Value in Health 2016 (In Press). ID - ref45 ER - TY - JOUR AU - Webster, K. AU - Odom, L. AU - Peterman, A. PY - 1999 DA - 1999// TI - The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Validation of version 4 of the core questionnaire JO - Qual Life Res VL - 8 ID - Webster1999 ER - TY - JOUR AU - Reilly, M. C. AU - Zbrozek, A. S. AU - Dukes, E. M. PY - 1993 DA - 1993// TI - The validity and reproducibility of a work productivity and activity impairment instrument JO - Pharmaco Economics VL - 4 UR - https://doi.org/10.2165/00019053-199304050-00006 DO - 10.2165/00019053-199304050-00006 ID - Reilly1993 ER - TY - STD TI - Chou R, Clark E, Helfand.Screening for Hepatitis C Virus Infection- Systematic Evidence Reviews, No. 24. http://www.ncbi.nlm.nih.gov/books/NBK43249/. UR - http://www.ncbi.nlm.nih.gov/books/NBK43249/ ID - ref48 ER - TY - JOUR AU - Wedemeyer, H. AU - Duberg, A. S. AU - Buti, M. AU - Rosenberg, W. M. AU - Frankova, S. AU - Esmat, G. AU - Örmeci, N. PY - 2014 DA - 2014// TI - Strategies to manage hepatitis C virus (HCV) disease burden JO - J Viral Hepat VL - 21 Suppl 1 UR - https://doi.org/10.1111/jvh.12249 DO - 10.1111/jvh.12249 ID - Wedemeyer2014 ER - TY - JOUR AU - Razavi, H. AU - Bruggmann, P. AU - Wedemeyer, H. AU - Dore, G. PY - 2014 DA - 2014// TI - Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue JO - J Viral Hepat VL - 21 UR - https://doi.org/10.1111/jvh.12339 DO - 10.1111/jvh.12339 ID - Razavi2014 ER - TY - JOUR AU - Rodger, A. J. AU - Jolley, D. AU - Thompson, S. C. AU - Lanigan, A. AU - Crofts, N. PY - 1999 DA - 1999// TI - The impact of diagnosis of hepatitis C virus on quality of life JO - Hepatology VL - 30 UR - https://doi.org/10.1002/hep.510300504 DO - 10.1002/hep.510300504 ID - Rodger1999 ER - TY - STD TI - Loria A, Doyle K, Weinstein AA, Winter P, Escheik C, Price J, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi ZM. Multiple Factors Predict Physical Performance in People with Chronic Liver Disease. Am J Phys Med Rehabil. 2014 Jan 6. [Epub ahead of print]. ID - ref52 ER - TY - JOUR AU - Kallman, J. AU - O’Neil, M. M. AU - Larive, B. AU - Boparai, N. AU - Calabrese, L. AU - Younossi, Z. M. PY - 2007 DA - 2007// TI - Fatigue and health-related quality of life (HRQOL) in chronic hepatitis C virus infection JO - Dig Dis Sci VL - 52 UR - https://doi.org/10.1007/s10620-006-9708-x DO - 10.1007/s10620-006-9708-x ID - Kallman2007 ER - TY - STD TI - Boscarino JA1, Lu M, Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Schmidt MA, Vijayadeva V, Holmberg SD. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The chronic hepatitis cohort study (CHeCS). Hepatology. 2014 Sep 9. doi: 10.1002/hep.27422. [Epub ahead of print]. ID - ref54 ER -